Usability of a Multimodal External Neuromodulatory Device to Relieve Acute Low Back Pain

Sponsor
MMJ Labs LLC (Industry)
Overall Status
Completed
CT.gov ID
NCT04494841
Collaborator
Sport and Spine Rehab Clinical Research Foundation (Other)
20
1
1
13.1
1.5

Study Details

Study Description

Brief Summary

Ten patients with acute or chronic low back pain will be invited to try a multimodal device for 20 minutes. Pain will be recorded prior to and after use, and feedback on the device will be elicited.

Condition or Disease Intervention/Treatment Phase
  • Device: Duotherm VibraCool Back Device
N/A

Detailed Description

To facilitate data collection of a short-term intervention, the investigators chose to enroll patients from a mixed physical therapy/chiropractic practice with demographic and economic diversity in the metro Washington area. The neuromodulatory device will have patient controlled frequencies at 50Hz, 100Hz, and 180Hz attached to a 12 x 22 cm metal plate ergonomically curved to fit the low back. The device will be wearable with a neoprene belt on both sides for patients to adjust pressure. The metal pocket in our device holds a 221g clay pack capable of being frozen to 15F or heated to 110F or patient tolerance, with 30 minute thermal capacity. A convenience sample of 10 patients at the clinic was invited to give feedback on the prototype device after informed consent. Changes suggested were incorporated and after informed consent a second group of ten gave will give feedback with the production-ready device.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Consecutive low back pain patients were offered to try a new device and give feedback on a prototype. Once the feedback was obtained, the changes were incorporated into a production-ready model and re-evaluated.Consecutive low back pain patients were offered to try a new device and give feedback on a prototype. Once the feedback was obtained, the changes were incorporated into a production-ready model and re-evaluated.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Addressing Feasibility of the DuoTherm in Acute and Chronic Low Back Pain
Actual Study Start Date :
Jan 17, 2020
Actual Primary Completion Date :
Jan 20, 2021
Actual Study Completion Date :
Feb 18, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: DuoTherm VibraCool Back Device

Patients will be offered a pain relief belt device incorporating multiple speeds of vibration and optional heat, cold, and pressure delivered through a sculpted metal plate. They will be able to choose from 8 patterns of vibration with the multiple motors (50, 100, 200Hz), and hot or cold, and will wear the device for 20 minutes.

Device: Duotherm VibraCool Back Device
Low back plate belt with mechanicothermal and pressure intervention options.

Outcome Measures

Primary Outcome Measures

  1. Change in pain: 10cm Visual Analog Scale (VAS) printed on paper from 0 (no pain) to 10 (most pain) [30 minutes]

    Difference between initial VAS and VAS after use of device

  2. Participants' choice in thermal options [30 minutes]

    One of four options: hot, cold, none, both

  3. Would you recommend [After 30 minutes]

    Binary approval or disapproval of device

Secondary Outcome Measures

  1. Subjective pain relief [30 minutes]

    7-item Likert scale of 1 (much worse) to 7 (much better) pain relief over the time of the study

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Acute or chronic low back pain as chief complaint

  • Capacity to understand all relevant risks and potential benefits of the study (informed consent);

  • Willingness to communicate information

Exclusion Criteria:
  • Radicular pain likely reflecting a surgical or mechanical problem

  • BMI greater than 30 (device won't fit)

  • Sensitivity to cold or vibration (e.g Raynaud's or Sickle Cell Disease)

  • Diabetic neuropathy rendering a patient unable to determine if the device is too hot

  • New neurologic deficits

  • Skin lesions over the low back area

  • Contraindication to any medication for pain management that would impact analgesic use record

  • Inability to apply DuoTherm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sport and Spine Rehab Clinic Rockville Maryland United States 20852

Sponsors and Collaborators

  • MMJ Labs LLC
  • Sport and Spine Rehab Clinical Research Foundation

Investigators

  • Principal Investigator: Amy Baxter, MD, MMJ Labs LLC

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Amy Lynn Baxter, Principal Investigator, MMJ Labs LLC
ClinicalTrials.gov Identifier:
NCT04494841
Other Study ID Numbers:
  • UsabilityDuoTherm
First Posted:
Jul 31, 2020
Last Update Posted:
Mar 17, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Amy Lynn Baxter, Principal Investigator, MMJ Labs LLC
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2021